AJANTPHARM Q1 FY27 results at a glance
AJANTA PHARMA LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹1,626 cr |
|---|
| Revenue YoY | +24.8% |
|---|
| Operating profit | ₹873 cr |
|---|
| Operating margin | 53.7% |
|---|
| Net profit | ₹334 cr |
|---|
| Net profit YoY | +30.9% |
|---|
| Net profit QoQ | +25.3% |
|---|
| Net margin | 20.6% |
|---|
| Basic EPS | ₹26.75 |
|---|
| TTM revenue | ₹5,725 cr |
|---|
| TTM net profit | ₹1,130 cr |
|---|
| TTM net margin | 19.7% |
|---|
AJANTPHARM Q1 FY27 results: what the numbers say
AJANTA PHARMA LIMITED (AJANTPHARM) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹1,626 cr and a net profit of ₹334 cr, translating into earnings per share of ₹26.75.
Compared with the same quarter a year earlier, revenue grew strongly by +24.8% and net profit grew strongly by +30.9%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹873 cr, an operating margin of 53.7% versus 52.4% a year ago — a gain of 1.3 percentage points.
AJANTPHARM quarter-wise results table
Revenue
₹1,626 cr
+24.8% YoY
Net profit
₹334 cr
+30.9% YoY
Operating profit
₹873 cr
+27.8% YoY
AJANTA PHARMA LIMITED (AJANTPHARM) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹1,626 cr | ₹873 cr | ₹334 cr | 53.7% | 20.6% | ₹26.75 | +30.9% | +25.3% |
| Q4 FY262026-03-31 | ₹1,422 cr | ₹731 cr | ₹267 cr | 51.4% | 18.8% | ₹21.35 | +18.4% | -2.6% |
| Q3 FY262025-12-31 | ₹1,375 cr | ₹715 cr | ₹274 cr | 52.0% | 19.9% | ₹21.91 | — | +7.2% |
| Q1 FY262025-06-30 | ₹1,303 cr | ₹683 cr | ₹255 cr | 52.4% | 19.6% | ₹20.44 | — | +13.4% |
| Q4 FY252025-03-31 | ₹1,170 cr | ₹567 cr | ₹225 cr | 48.5% | 19.2% | ₹18.00 | — | — |
| TTM (last 4 quarters) | ₹5,725 cr | ₹3,000 cr | ₹1,130 cr | 52.4% | 19.7% | ₹90.45 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
AJANTPHARM quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
AJANTA PHARMA LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹1,626 cr | ₹1,422 cr | ₹1,375 cr | ₹1,303 cr | ₹1,170 cr |
|---|
| Total expenses | ₹753 cr | ₹691 cr | ₹660 cr | ₹620 cr | ₹603 cr |
|---|
| Gross profit | ₹1,298 cr | ₹1,117 cr | ₹1,089 cr | ₹1,027 cr | ₹887 cr |
|---|
| Operating profit (EBIT) | ₹873 cr | ₹731 cr | ₹715 cr | ₹683 cr | ₹567 cr |
|---|
| Operating margin | 53.7% | 51.4% | 52.0% | 52.4% | 48.5% |
|---|
| Interest cost | ₹3.18 cr | ₹2.36 cr | ₹5.1 cr | ₹5.26 cr | ₹6.07 cr |
|---|
| Profit before tax | ₹447 cr | ₹347 cr | ₹359 cr | ₹331 cr | ₹269 cr |
|---|
| Tax expense | ₹113 cr | ₹80.41 cr | ₹84.83 cr | ₹75.79 cr | ₹44.15 cr |
|---|
| Effective tax rate | 25.2% | 23.2% | 23.7% | 22.9% | 16.4% |
|---|
| Net profit (PAT) | ₹334 cr | ₹267 cr | ₹274 cr | ₹255 cr | ₹225 cr |
|---|
| Net profit margin | 20.6% | 18.8% | 19.9% | 19.6% | 19.2% |
|---|
| Basic EPS | ₹26.75 | ₹21.35 | ₹21.91 | ₹20.44 | ₹18.00 |
|---|
| Diluted EPS | ₹26.72 | ₹21.34 | ₹21.91 | ₹20.43 | ₹18.00 |
|---|
AJANTPHARM results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|
| Revenue YoY | +24.8% | +21.5% | — | — | — |
|---|
| Revenue QoQ | +14.4% | +3.4% | +5.5% | +11.3% | — |
|---|
| Operating profit YoY | +27.8% | +28.8% | — | — | — |
|---|
| Operating profit QoQ | +19.4% | +2.3% | +4.7% | +20.3% | — |
|---|
| Net profit YoY | +30.9% | +18.4% | — | — | — |
|---|
| Net profit QoQ | +25.3% | -2.6% | +7.2% | +13.4% | — |
|---|
| EPS YoY | +30.9% | +18.6% | — | — | — |
|---|
| EPS QoQ | +25.3% | -2.6% | +7.2% | +13.6% | — |
|---|
AJANTPHARM annual results history
Full-year performance for AJANTA PHARMA LIMITED, useful for reading each quarter in context.
AJANTA PHARMA LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹5,407 cr | ₹4,588 cr | ₹4,162 cr | ₹3,708 cr |
|---|
| Total expenses | ₹4,081 cr | ₹3,459 cr | ₹3,116 cr | ₹3,028 cr |
|---|
| Gross profit | ₹4,160 cr | ₹3,460 cr | ₹3,046 cr | ₹2,591 cr |
|---|
| Operating profit (EBIT) | ₹1,327 cr | ₹1,128 cr | ₹1,046 cr | ₹680 cr |
|---|
| Operating margin | 24.5% | 24.6% | 25.1% | 18.3% |
|---|
| Interest cost | ₹16.11 cr | ₹20.73 cr | ₹7.21 cr | ₹5.84 cr |
|---|
| Profit before tax | ₹1,378 cr | ₹1,189 cr | ₹1,114 cr | ₹745 cr |
|---|
| Tax expense | ₹322 cr | ₹269 cr | ₹298 cr | ₹157 cr |
|---|
| Effective tax rate | 23.3% | 22.6% | 26.7% | 21.1% |
|---|
| Net profit (PAT) | ₹1,056 cr | ₹920 cr | ₹816 cr | ₹588 cr |
|---|
| Net profit margin | 19.5% | 20.1% | 19.6% | 15.9% |
|---|
| Basic EPS | ₹84.53 | ₹73.56 | ₹64.82 | ₹45.89 |
|---|
| Diluted EPS | ₹84.51 | ₹73.53 | ₹64.77 | ₹45.89 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹1,626 cr against ₹1,303 cr in Q1 FY26, and ₹1,422 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +14.4%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹753 cr, or 46.3% of revenue, with operating profit grew +27.8% year on year.
Margins, tax and profitability
Net profit of ₹334 cr works out to a net margin of 20.6% compared with 19.6% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, AJANTA PHARMA LIMITED reported profit before tax of ₹447 cr, a tax charge of ₹113 cr (effective rate 25.2%), interest cost of ₹3.18 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹267 cr in Q4 FY26 to ₹334 cr in Q1 FY27, a change of +25.3%.
Trailing twelve months and annual context
Across the trailing four quarters AJANTA PHARMA LIMITED has generated revenue of ₹5,725 cr and net profit of ₹1,130 cr, a trailing net margin of 19.7%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹5,407 cr with net profit of ₹1,056 cr and EPS of ₹84.53, versus the prior year where revenue grew +17.9% and profit grew +14.7%.
What to watch in the next AJANTPHARM quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
AJANTA PHARMA LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
AJANTPHARM results coverage
No results report published for AJANTPHARM yet — our desk covers each quarter within minutes of the filing.
AJANTPHARM quarterly results FAQs
What were AJANTA PHARMA LIMITED (AJANTPHARM) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), AJANTA PHARMA LIMITED reported revenue of ₹1,626 cr and net profit of ₹334 cr, a change of +30.9% year on year on +24.8% revenue growth. EPS stood at ₹26.75.
What is AJANTPHARM profit margin in Q1 FY27?
AJANTA PHARMA LIMITED posted a net profit margin of 20.6% and an operating margin of 53.7% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹5,725 cr and net profit ₹1,130 cr.
Did AJANTPHARM results beat the previous quarter?
AJANTA PHARMA LIMITED net profit changed +25.3% quarter on quarter, from ₹267 cr in Q4 FY26 to ₹334 cr in Q1 FY27.
When are AJANTA PHARMA LIMITED (AJANTPHARM) quarterly results?
AJANTA PHARMA LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see AJANTPHARM latest quarterly results?
Results coverage for AJANTPHARM will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the AJANTPHARM stock page.
What is AJANTA PHARMA LIMITED annual revenue and profit?
For FY26, AJANTA PHARMA LIMITED reported full-year revenue of ₹5,407 cr and net profit of ₹1,056 cr, with EPS of ₹84.53.
How many quarterly results has AJANTPHARM declared recently?
Past results dates for AJANTPHARM will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
